Inhibition of STAT4 activation by lisofylline is associated with the protection of autoimmune diabetes

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 409-411

  Yang, Zandong ^a   Chen, Meng ^a   Fialkow, Lawrence B ^a   Ellett, Justin D ^a   Wu, Runpei ^a   Nadler, Jerry L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmune diabetes; IL 12; Lisofylline; NOD mice; STAT4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LISOFYLLINE; MESSENGER RNA; PROTEIN INHIBITOR; SODIUM CHLORIDE; STAT4 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; CELL INFILTRATION; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HISTOCHEMISTRY; IMMUNOPROPHYLAXIS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS; PHARMACOLOGICAL BLOCKING; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALIA;

EID: 1642282126     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.069     Document Type: Conference Paper

References (8)

1. SCHRANZ, D.B. & A. LERNMARK. 1998. Immunology in diabetes: an update. Diabetes Metab. Rev. 14: 3-29.
2. TREMBLEAU, S., G. PENNS, E. BOSI et al. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821.
3. KUKREJA, A. & N.K. MACLAREN. 1999. Autoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84: 4371-4378.
4. ADORINI, L., J.C. GUERY & S. TREMBLEAU. 1996. Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diabetes? Autoimmunity 23: 53-68.
5. 2. Diabetologia 40: 641-646.
6. YANG, Z., M. CHEN, R. WU et al. 2002. The anti-inflammatory compound lisofylline prevents type 1 diabetes in non-obese diabetic mice. Diabetologia 45: 1307-1314.
7. CHEN, M., Z. YANG, R. WU & J.L. NADLER. 2002. Lisofylline, a novel antiinflammatory agent, protects pancreatic β-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 143: 2341-2348.
8. COON, M.E., M. DIEGEL, N. LESHINSKY & S.J. KLAUS. 1998. Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling. J. Immunol. 163: 6567-6574.